This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

GRAMMY Winning Country Music Trio Lady Antebellum Joins The Leukemia & Lymphoma Society In National Awareness Campaign

WHITE PLAINS, N.Y., Nov. 6, 2012 /PRNewswire/ -- Seven-time Grammy-award winning country music trio Lady Antebellum join with The Leukemia & Lymphoma Society (LLS) for a new public service campaign to raise awareness and dollars for the lifesaving cancer research funded by the organization.

(Photo: http://photos.prnewswire.com/prnh/20121106/NY07039 )

"Like most people, cancer has touched someone close to each of us recently," said Haywood. "So, it's something that's important to us and we're proud to support The Leukemia & Lymphoma Society's efforts to raise funds for cancer research."

All three band members, Hillary Scott, Charles Kelley, and Dave Haywood, have a strong connection to the LLS mission, each with a family member diagnosed with cancer in the past two years. In the new PSA, Scott talks openly about losing her grandfather to acute myeloid leukemia and his influence on the group.  Having been impacted by cancer recently, they share their hope that cancer will be cured in their lifetime. The band urges viewers to donate to LLS to help find cures.

The PSA campaign, directed by filmmaker Jesse Dylan, is being distributed nationally on broadcast and in print.

"Lady Antebellum is an extremely talented and celebrated band and we are so grateful that they are giving their time and energy to support The Leukemia & Lymphoma Society," said John Walter, LLS President and CEO. "LLS is funding the most promising blood cancer research around the world and with Lady Antebellum's help we continue helping patients live longer, better lives."

Critical treatment innovations have originated through blood cancer research, including radiation, chemotherapy, stem cell transplantation, and new-targeted therapies, and significant progress continues to be made. Blood cancer research has been a gateway to finding therapies for many types of cancers.  Half of the cancer drugs approved by the FDA in the last decade were first approved to treat patients with blood cancer, and many of these drugs are now being used and/or showing promise as treatments for patients with solid tumors and serious autoimmune diseases.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,106.70 +29.83 0.17%
S&P 500 2,000.02 +2.10 0.11%
NASDAQ 4,570.6370 +13.29 0.29%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs